Clinical Trials Browser

Has results × Waldenstrom Macroglobulinemia × Dasatinib × Clear all

NCT04115059 2024-03-21

Dasatinib In Waldenström Macroglobulinemia

Phase 1 Terminated

3 enrolled 13 charts

Waldenstrom Macroglobulinemia